Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat

Life Sciences

Volumn 67, Issue 1, 2000, Pages 61-71

  Kim, Kee Won ^a   Woo, Ran Sook ^a   Kim, Chul Jin ^a   Cheong, Young Pyo ^b   Kim, Jong Keun ^c   Kwun, Jin ^a   Cho, Kyu Park ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Wonkwang University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Human cerebral cortex; Met enkephalin Arg6 Phe7; Norepinephrine release; Opioid receptor selectivity; Rat cortex slices

Indexed keywords

BREMAZOCINE; DELTA OPIATE RECEPTOR; DERMORPHIN DERIVATIVE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; KAPPA OPIATE RECEPTOR; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NORADRENALIN; NORBINALTORPHIMINE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ADULT; AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN CORTEX; BRAIN MEMBRANE; BRAIN SLICE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NORADRENALIN RELEASE; RADIORECEPTOR ASSAY; RAT; RECEPTOR BINDING;

ADULT; ANIMALS; BENZENEACETAMIDES; BENZOMORPHANS; BINDING SITES; CEREBRAL CORTEX; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, METHIONINE; ETHYLKETOCYCLAZOCINE; FEMALE; HUMANS; MALE; NALOXONE; NALTREXONE; NOREPINEPHRINE; OLIGOPEPTIDES; PEPTIDES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 0034717155     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00606-8     Document Type: Article

References (38)

1. P. Giraud, E. Castanas, G. Patey, C. Oliver and J. Rossier, J. Neurochem. 41 154-160 (1983).
2. A.S. Stern, R.V. Lewis, S. Kimura, J. Rossier, L.D. Gerber, L. Brink, S. Stein and S. Udenfriend, Proc. Natl. Acad. Sci. USA. 76 6680-6683 (1979).
3. D.L. Kilpatrick, R.D. Howells, H.-W. Lahn and S. Udenfriend, Proc. Natl. Acad. Sci. USA 80 5772-5775 (1983).
4. I. Lindberg and L. White, Arch. Biochem. Biophys. 245 1-7 (1986).
5. J. Rossier, Y. Audigier, N. Ling, J. Cros and S. Udenfriend, Nature 288 88-90 (1980).
6. F. Tang, J. Tang, J Chou and E. Costa, Life Sci. 35 1005-1014 (1984).
7. C.W. Pittius, B.R. Seizinger, A. Pasi, P. Mehraein and A. Herz, Brain Res. 304 127-136 (1984).
8. J.S. Han, H. Fei and Z.F. Zhou, Brain Res. 322 289-296 (1984).
9. I. Nylander, P. Hyytia, O. Forsander and L. Terenius, Alcohol Clin. Exp. Res. 18 1271-1279 (1994).
10. J. Kamei, Y. Iwamoto, M. Misawa, H. Nagase and Y. Kasuya, Eur. J. Pharmacol. 253 293-296 (1994).
11. H.S. Sharma, F. Nyberg, M. Thornwall and Y. Olson, Neuropharmacology 32 711-717 (1993).
12. Z. Mateo, L.Napier, J.F. Gaugl, B.A. Barron and J.L. Caffrey, Am. J. Physiol. 269 H2082-2089 (1995).
13. C.E. Intussi, J.G. Umans, D. Wolff, A.S. Stern, R.V. Rewis, S. Stein and S. Udenfriend, Proc. Natl. Acad. Sci. USA 77 5512-5514 (1982).
14. S.J. Paterson, A.D. Corbett, M.G.C. Gillan, H.W. Kosterlitz, A.T. McKnight, and L.E. Robson, J. Receptor Res. 4 143-154 (1984).
15. M. Wollemann, J. Farkas, G. Toth and S. Benhye, J. Neurochem. 63 1460-1465 (1994).
16. S. Benhye, J. Farkas, G. Toth and M. Wollemann, J, Neurosci. Res. 48 249-258 (1997).
17. R.S. Zukin, M. Eghbali, D. Olive, E.M. Unterwald and A. Tempel, Proc. Natl. Acad. Sci. USA 85 4061-4065 (1988).
18. K.W. Kim, Y.A. Eun, S.M. Soh, J.S. Eun and K.P. Cho, Life Sci. 58 1671-1679 (1996).
19. P.J. Munson and D. Rodbard, Anal. Biochem. 107 220-226 (1980).
20. O.H. Lowry, N.J. Rosebrough, L. Farr and R.J. Randall, J. Biol. Chem. 193 265-273 (1951).
21. L.L. Werling, S.R. Brown and B.M. Cox, Neuropharmacol. 26 987-996 (1987).
22. A. De Lean, P.J. Munson, V. Guardabasso and D. Rodbard, A User's Guide to Allfit. Lab. Theoret. Physical Biol., Nat'l Inst. Child Hlth, NIH, Bethesda (1988).
23. R.J. Tallarida and R.R. Murray, Manual of Pharmacologic Calculation 2nd Ed., Springer Verlag, New York (1986).
24. T.H. Kramer, J.E. Shook, W. Kazmierski, E.A. Ayres, W.S. Wire, V.J. Hruby and T.F. Burks, J. Pharmacol. Exp. Ther. 249 544-551 (1989).
25. P.S. Portoghese, H. Nagase, A.W. Lipkowski, D.L. Larson and A.E. Takemori, J. Med. Chem. 31 836-841 (1988).
26. R.E. Chipkin and R.W. Chapman, Life Sci. 34 1809-1817 (1984).
27. J.P. Mathis, J. Ryan-Moro, A. Chang, J.S.H. Hom, D.A. Scheinberg and G.W. Pasternak, Biochem. Biophys. Res. Commun. 230 462-465 (1997).
28. A. Pfeiffer, A. Pasi, P. Meheraein, and A. Herz, Neuropeptides 2 89-97 (1981).
29. P.F. von Voigtlander, R.A. Lahti, and J.H. Ludens, J. Pharmacol. Exp. Ther. 224 7-12 (1983).
30. R.A. Lahti, M.M. Mickerson, J.M. McCall, and P.F. von Voigtlander, Eur. J. Pharmacol. 109 281-284 (1985).
31. M. Tiberi, and J. Magnan, Mol. Pharmacol. 37 694-703 (1990).
32. R.B. Rothman, V. Bykov, B.R. De Costa, A.E. Jacobson, K.C. Rice, and L.S. Brady, Peptides 11 311-331 (1990).
33. B. Nock, A.L. Giordano, T.J. Cicero, and L.H. O'Connor, J. Pharmacol. Exp. Ther. 254 412-429 (1990).
34. B. Attali, C. Gouarderes, H. Mazarguil, Y. Audigier and J. Cros, Neuroprptides 3 53-64 (1982).
35. C. Gouarderes, B. Attali, Y. Audigier and J. Cros, Life Sci. 33(Suppl. 1) 175-178 (1983).
36. K.W. Kim and B.M. Cox, J. Pharmacol. Exp. Ther. 267 1153-1160 (1993)
37. L.L. Werling, P.N. McMahon and B.M. Cox, J. Pharmacol. Exp. Ther. 247 1103-1106 (1988).
38. R. Spanagel, O.F.X. Almeida and T.S. Shippenberg, Eur. J. Pharmacol. 264 157-162 (1994).